EP1827492
ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.11.2005EP published:
11.8.2010EP application number:
05852645.0
EPO information:
European Patent Register
Max expiry date:
29.11.2025
Title:
ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF
Timeline
Today
30.11.2005EP application
11.8.2010EP Publication
Owner
Name:
Celldex Therapeutics, Inc.Address:
119 Fourth Avenue, 02494, Needham, MA, US
Name:
Amgen Fremont Inc.Address:
6701 Kaiser Drive, 94555, Fremont, CA, US
Inventor
Name:
RASTELLI, LucaAddress:
Union City, CA, US
Name:
POLLACK, Vincent, A.Address:
Los Angeles, CA, US
Name:
TSE, Kam, FaiAddress:
Fremont, CA, US
Name:
KLAKAMP, ScottAddress:
Foster City, CA, US
Name:
FOORD, OritAddress:
Fremont, CA, US
Name:
LIANG, MeinaAddress:
Clinton, CT, US
Name:
JIA, Xiao-ChiAddress:
Gales Ferry, CT, US
Name:
XIAO, FengAddress:
Guilford, CT, US
Name:
LICHENSTEN, HenriAddress:
Guilford,Connecticut, US
Name:
HERRMANN, JohnAddress:
Guilford, Connecticut, US
Name:
LAROCHELLE, William, J.Address:
Branford, CT, US
Name:
JEFFERS, Michael, E.Address:
Madison, CT, US
Name:
CHAPOVAL, AndreiAddress:
Northford, CT, US
Name:
MEZES, PeterAddress:
Old Lyme, CT, US
Name:
ARA, GulshanAddress:
Northford,Connecticut, US
Name:
TORGOV, MichaelAddress:
Middletown, CT, US
Name:
KARKARIA, CyrusAddress:
Branford, CT, US
Name:
DAVAGNINO, JuanAddress:
Madison, CT, US
Priority
Number:
632023 PDate:
30.11.2004Country:
US
Number:
733779 PDate:
7.11.2005Country:
US
Classification
Categories:
A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/30, C07K 19/00, C12N 1/21, C12N 15/13, C12N 15/63, C12N 5/10, G01N 33/574, G01N 33/577